• The efficacy of desipramine for mild depression was tested in a double-blind, placebo-controlled study of outpatients with scores below 19 on the Hamilton Rating Scale for Depression (HAM-D). Of 103 such patients, 23 dropped out and 16 improved during a ten-day placebo period. Among 64 patients completing the randomized portion of the study, significantly more improved with desipramine than with placebo. The Research Diagnostic Criteria (RDC) category of major depressive disorder largely accounted for the drugplacebo response difference found for the entire sample. Patients with intermittent depressive disorder improved significantly less frequently with desipramine than patients with major depressive disorder. Independent of RDC diagnosis, severity of illness correlated with outcome. Thus, patients with pretreatment HAM-D scores at or above the median demonstrated significant drug effect, while patients with lower pretreatment HAM-D scores did not.
Stewart JW, Quitkin FM, Liebowitz MR, McGrath PJ, Harrison WM, Klein DF. Efficacy of Desipramine in Depressed Outpatients: Response According to Research Diagnostic Criteria Diagnoses and Severity of Illness. Arch Gen Psychiatry. 1983;40(2):202–207. doi:10.1001/archpsyc.1983.01790020100010
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.